Comparison of Recombinant Tissue Factor Pathway Inhibitors Expressed in Human SK Hepatoma, Mouse C127, Baby Hamster Kidney, and Chinese Hamster Ovary Cells

Summary

Recombinant tissue factor pathway inhibitor (rTFPI) has been expressed in four mammalian expression systems using human SK hepatoma, mouse C127, baby hamster kidney (BHK), and Chinese hamster ovary (CHO) cells as hosts. On sodium dodecyl sulfate polyacrylamide gel electrophoresis, the immunoaffinity purified rTFPIs all show broad bands and the mean molecular weight of SK hepatoma and C127 rTFPIs (M _r ~ 38,000) appear larger than those of BHK and CHO rTFPIs (M _r ~ 35,000). All these proteins inhibit factor Xa and appear to bind factor Xa with 1:1 stoichiometry. The ability of these proteins to inhibit tissue factor-induced coagulation in plasma was examined using a prothrombin time assay. The relative activities of SK rTFPI:C127 rTFPI:BHK rTFPI:CHO rTFPI were found to be 28:15:2.1:1. By Western blot using specific antisera against the amino- and carboxy-termini of TFPI as probes, it is found that all the immunoaffinity purified rTFPIs possess approximately equal amounts of the amino terminus, but the C127 and BHK rTFPIs are deficient in carboxy terminus and the CHO rTFPI is essentially devoid of this region of the protein. Mono S chromatography allowed separation of the full-length and the truncated molecules with high and low anticoagulant activities, respectively. The above results suggest that proteolysis of the carboxy terminus of TFPI occurs to different extent when TFPI is expressed in different cells and that the carboxy terminal region of the TFPI molecule is important for the inhibition of tissue factor-induced coagulation. Recombinant and non-recombinant SK hepatoma cells appear to produce TFPI with the least amount of proteolysis compared with other cell systems tested and SK TFPI functionally resembles TFPI circulating in the blood.

• References

• 1 Nemerson Y. Tissue factor and hemostasis. 1988; 71: 1-8
• 2 Rapaport SI. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 1989; 73: 359-365
• 3 Broze Jr GJ, Girard TG, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546
• 4 Rao LVM, Rapaport SI. Studies on the mechanism of inactivation of the extrinsic pathway of coagulation. Blood 1987; 69: 645-651
• 5 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-343
• 6 Wun T-C, Kretzmer KK, Girard TJ, Miletich JP, Broze Jr GJ. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-6004
• 7 Broze Jr GJ, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma. Proc Natl Acad Sci USA 1987; 84: 1886-1890
• 8 Wun T-C, Huang MD, Kretzmer KK, Palmier MO, Day KC, Bulock JW, Fok KF, Broze Jr GJ. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. J Biol Chem 1990; 265: 16096-101
• 9 Day KC, Hoffman LC, Palmier MO, Kretzmer KK, Huang MD, Pyla EY, Spokas E, Broze Jr GJ, Warren TG, Wun T-C. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood 1990; 76: 1538-1545
• 10 Subramani S, Mulligan R, Berg P. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors. Mol Cell Biol 1981; 1: 854-864
• 11 Urlaub G, Chasin LA. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 1980; 77: 4216-4220
• 12 Schimke RT. Gene amplification in cultured animal cells. Cell 1984; 37: 705-713
• 13 Fogh J, Trempe G. New human tumor cell lines. In: Human Tumor Cells In Vitro. Plenum Press; New York: 1975: 115-159
• 14 Blochlinger K, Diggelmann H. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol Cell Biol 1984; 4: 2929-2931
• 15 Ishii S-H, Yokosawa H, Kumazaki T, Nakamura I. Immobilized anhydrotrypsin as a specific affinity adsorbent for tryptic peptides. Methods Enzymol 1983; 91: 378-383
• 16 Girard TJ, McCourt D, Novotny WF, MacPhail LA, Likert KM, Broze Jr GJ. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2. Biochem J 1990; 270: 621-625
• 17 Wesselschmidt R, Likert K, Girard T, Wun T-C, Broze Jr GJ. Lipoprotein-associated coagulation inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa. (Submitted)
• 18 Girard TJ, Warren LA, Novotony WF, Likert KM, Brown SG, Miletich JP, Broze Jr GJ. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-520
• 19 Welsch DJ, Novotny WF, Wun T-C. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Thromb Res 1991; 64: 213-222
• 20 Sandset PM, Sirnes PA, Abildgaard U. Factor VII and extrinsic pathway inhibitor in acute coronary disease. Br J Haematol 1989; 72: 391-396
• 21 Warr TA, Warn-Cramer BJ, Rao LVM, Rapaport SI. Human plasma extrinsic pathway inhibitor (EPI) activity: I. Standardization of assay and evaluation of physiological variables. Blood 1989; 74: 201-206
• 22 Nordfang O, Bjorn SE, Valentin S, Nielsen LS, Wildgoose P, Beck T, Hedner U. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 1991; 30: 10371-10376
• 23 Colburn P, Crabb JW, Buonassisi V. Enhanced inhibition of tissue factor by the extended form of an endothelial cell gylcoprotein (an extrinsic pathway inhibitor). J Cell Physiol 1991; 148: 320-326